Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma With Portal Vein Tumor Thrombus”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Not applicableUnknownNCT03730675
What this trial is testing

Irradiation Stent Placement Plus TACE for HCC and PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Zhongda Hospital 308
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Large-scale testing (Phase 3)UnknownNCT02971345
What this trial is testing

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 253
Not applicableActive Not RecruitingNCT06248528
What this trial is testing

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

Who this might be right for
Hepatocellular Carcinoma
Chen Xiaoping 1,076
Not applicableUnknownNCT05530785
What this trial is testing

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Yongchang Zhang 35
Post-approval studies (Phase 4)Looking for participantsNCT07132515
What this trial is testing

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Who this might be right for
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University 100
Large-scale testing (Phase 3)UnknownNCT04319484
What this trial is testing

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusLiver Transplantation
RenJi Hospital 108
Testing effectiveness (Phase 2)UnknownNCT06210334
What this trial is testing

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)

Who this might be right for
Hepatocellular Carcinoma With PVTT
Li Xiao Wei 54
Not applicableStudy completedNCT04618367
What this trial is testing

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Who this might be right for
Carcinoma, HepatocellularLiver NeoplasmsSintilimab+1 more
Sun Yat-sen University 30
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Large-scale testing (Phase 3)Ended earlyNCT01887717
What this trial is testing

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 36
Not applicableEnded earlyNCT01690715
What this trial is testing

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery

Who this might be right for
Hepatocellular CarcinomaPortal Vein ThrombosisHepatic Portal Vein Tumor Invasion
Hospital Sirio-Libanes 50
Large-scale testing (Phase 3)UnknownNCT04025437
What this trial is testing

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 214
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Post-approval studies (Phase 4)Ended earlyNCT01600196
What this trial is testing

Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 126
Not applicableStudy completedNCT02571946
What this trial is testing

Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Who this might be right for
Liver NeoplasmPortal Vein Tumor ThrombosisProton Therapy
Samsung Medical Center 53
Not applicableWithdrawnNCT05592197
What this trial is testing

Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT

Who this might be right for
Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Large-scale testing (Phase 3)UnknownNCT02301091
What this trial is testing

Combine TACE and RFA Versus TACE Alone for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Ming Zhao 240
Load More Results